Oliver Wyman analysis details the performance of ACOs by type (physician-led, hospital-led, commercial) and offers insight into what it will take for each to be successful.
A comprehensive view of the ACO market, including a detailed look at “winners”, regional differences, and success rates by type.
Leaders from Oliver Wyman’s Actuarial Consulting break down how changes to the ACA individual market may play out on a state-by-state basis.
Direct-purchase agreements are being floated as a price-control strategy. But how is value defined? And when might low cost come at the expense of true value?
The leaders of GuideWell, parent of Florida Blue, and Alignment Healthcare discuss their “disruptive” population health collaboration.
New analysis reveals the pace (rapid) and shape (more joint ventures) of payer-provider partnerships.
Multi-year trend guarantees can break the annual renewal cycle and meet employers’ demand for certainty around health-benefit spend. Are you ready for a long-term commitment?
Tom Main shares 10 ways precision medicine will transform the healthcare landscape.
What will take to push precision medicine to the next level? Syapse Founder Jonathan Hirsch explains.
Even amidst the uncertainty of repeal and replace, we see some meaningful trends taking shape. Read our predictions for 2017.
Trendspotting in unpredictable times. This infographic highlights five predictions for 2017.
How Blue Cross Blue Shield of Texas is serving vulnerable populations through outreach and a variety of collaborative programs.
In the face of today’s market turmoil and revenue insecurity, ancillary products offer a stable, growing profit pool for health plans.